Private NIH Meeting Decides Fate of Heart Research Funding
Published Date: 3/17/2025
Notice
Summary
The National Heart, Lung, and Blood Institute is holding a private virtual meeting on April 16-17, 2025, to review grant applications. This meeting affects researchers seeking funding and keeps sensitive info safe. No public access means they’re protecting personal and trade secrets while deciding who gets money to support important health research.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Closed Grant Review Meeting
The National Heart, Lung, and Blood Institute will hold a closed, virtual meeting on April 16-17, 2025 (9:00 a.m. to 6:00 p.m.) to review and evaluate grant applications. The meeting is closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6).
Applicant Confidentiality Protected
The meeting is closed because discussing grant applications could disclose confidential trade secrets, patentable material, or personal information about applicants. That protection is in accordance with 5 U.S.C. 552b(c)(4) and 552b(c)(6).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12844 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings on July 17, 2026, to review important grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. Researchers applying for grants in brain injury, neurobehavior, nanotech, and heart/lung studies should note these review dates and prepare accordingly.
2026-12843 — Government Owned Inventions Available for License: C8166-45 Cell Line
The National Cancer Institute is offering a special human T-cell line called C8166-45 for licensing. This cell line helps scientists study viruses like HTLV-1 and HIV, which can cause serious diseases. Researchers and companies can now use this tool to develop better treatments, with licensing info available starting June 2026—no patents, just pure science power ready to roll!
2026-12842 — Government Owned Inventions Available for License: Compositions and Methods for Producing Dendritic Cell-based Vaccines With Enhanced Efficacy
The National Cancer Institute has created a new way to make cancer vaccines stronger by using special omega-3 fats to boost immune cells called dendritic cells. This could help scientists and companies develop better cancer treatments that work more effectively. If you’re in biotech or medicine, now’s the time to team up or license this exciting technology and help bring improved vaccines to patients faster.
2026-12585 — Submission for OMB Review; 30-Day Comment Request; Chimpanzee Research Use Form (Office of the Director)
The NIH wants to keep collecting info using the Chimpanzee Research Use Form and is asking the public to share thoughts by July 23, 2026. This form helps track how chimpanzees are used in research, affecting scientists and animal welfare groups. No big changes or costs are expected, just a smooth extension of the current form’s approval.
2026-12565 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for cool science projects. If you’re a researcher waiting on grants, these reviews shape the future of your funding and the science world!
2026-12244 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide funding for health research projects. Scientists and researchers applying for grants should note these dates as they impact which projects get money.
Previous / Next Documents
Previous: 2025-04207 — National Heart, Lung, and Blood Institute; Notice of Closed Meeting
The National Heart, Lung, and Blood Institute is holding a closed virtual meeting on April 22, 2025, to review and decide on grant applications. This meeting affects researchers seeking funding for heart, lung, and blood health projects and keeps sensitive info private. No public access or money changes are announced, but important funding decisions will be made behind the scenes.
Next: 2025-04209 — National Heart, Lung, and Blood Institute; Notice of Closed Meetings
The National Heart, Lung, and Blood Institute is holding secret virtual meetings in early April 2025 to review important grant applications. These closed sessions protect private info and trade secrets while deciding who gets funding to fight heart and lung diseases. Researchers and organizations applying for grants should watch these dates closely, as funding decisions could impact their projects and budgets.